Skip to main content
. 2017 Jan 19;28(6):1859–1866. doi: 10.1681/ASN.2016080828

Table 4.

Association of klotho with incident CKD (eGFR<60 ml/min per 1.73 m2 and >1 ml/min per yr decline)

Exposure N Incident CKD Rate, %/yr Model 1 Model 2 Model 3 Model 4
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Klotho, per doubling 1914 536 4.81 0.90 (0.79 to 1.02) 0.89 (0.77 to 1.01) 0.89 (0.77 to 1.02) 0.90 (0.78 to 1.04)
Klotho quartiles
 <479 438 134 5.11 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
 459–630 474 136 5.05 0.99 (0.79 to 1.23) 0.86 (0.69 to 1.07) 0.83 (0.66 to 1.03) 0.84 (0.67 to 1.05)
 631–816 485 130 4.46 0.87 (0.70 to 1.09) 0.84 (0.66 to 1.01) 0.81 (0.65 to 1.01) 0.84 (0.67 to 1.04)
 >816 517 136 4.68 0.92 (0.73 to 1.14) 0.92 (0.73 to 1.14) 0.91 (0.73 to 1.14) 0.93 (0.74 to 1.17)

Excludes those with eGFR<60 ml/min per 1.73 m2 at baseline. Model 1 = unadjusted analysis. Model 2 = adjusted for age, sex, race, study site, and baseline eGFR. Model 3 = Model 2+diabetes, cardiovascular disease, hypertension, and urine albumin-to-creatinine ratio. Model 4 = Model 3+calcium, phosphorus, parathyroid hormone, and FGF-23. Interactions: klotho × FGF-23, P=0.8; klotho × eGFR, P=0.7; klotho × phosphorus, P=0.2. OR, odds ratio; 95% CI, 95% confidence interval; ref, reference.